Biomea Fusion BMEA
NASDAQ BMEA
$1.37 +0.01 (+0.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biomea Fusion (BMEA) Shares Outstanding (2020 - 2026)

Biomea Fusion (BMEA) posted Shares Outstanding (Entity) of $72.3 million for Q1 2026, up 38.43% sequentially from $52.2 million in Q4 2025, and up 92.43% YoY from $37.6 million in Q1 2025.

Biomea Fusion (BMEA) Shares Outstanding (2020 - 2026) Analysis & Trends

Biomea Fusion has reported Shares Outstanding (Entity) for 7 years, with the latest figure at $72.3 million in Q1 2026.

  • Quarterly Shares Outstanding (Entity) rose 92.43% year-over-year to $72.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $72.3 million (up 92.43% YoY) and the FY2025 annual result came in at $52.2 million, up 43.84% from the prior year.
  • Shares Outstanding (Entity) climbed to $72.3 million in Q1 2026 per BMEA's latest filing, from $52.2 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $72.3 million in Q1 2026 and troughed at $29.2 million in Q1 2022.
  • A 5-year average of $38.9 million and a median of $35.9 million in 2024 frame the typical range for Shares Outstanding (Entity).
  • The widest YoY moves for Shares Outstanding (Entity): up 142.98% in 2022, down 1.0% in 2022.
  • Over 5 years, Shares Outstanding (Entity) stood at $29.6 million in 2022, then rose by 21.33% to $35.9 million in 2023, then climbed by 1.24% to $36.3 million in 2024, then surged by 43.84% to $52.2 million in 2025, then soared by 38.43% to $72.3 million in 2026.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $72.3 million, $52.2 million, and $59.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 62.19 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 398.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 111.58 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 133.61 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 241.70 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 217.35 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 445.06 Mn
10 Biomea Fusion 97.69 Mn 97.69 Mn - 72.36 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 72.36 Mn
Mar 31, 2026 72.30 Mn
Dec 31, 2025 52.23 Mn
Sep 30, 2025 59.85 Mn
Jun 30, 2025 40.63 Mn
Mar 31, 2025 36.63 Mn
Dec 31, 2024 36.11 Mn
Sep 30, 2024 36.22 Mn
Jun 30, 2024 36.04 Mn
Mar 31, 2024 35.89 Mn
Dec 31, 2023 34.11 Mn
Sep 30, 2023 35.65 Mn
Jun 30, 2023 35.35 Mn
Mar 31, 2023 29.59 Mn
Dec 31, 2022 29.27 Mn
Sep 30, 2022 29.32 Mn
Jun 30, 2022 29.20 Mn
Mar 31, 2022 29.13 Mn
Dec 31, 2021 23.86 Mn
Sep 30, 2021 29.00 Mn